# John Hanna

> John W. Hanna is President and CEO of CareDx, Inc., the leading transplant patient diagnostics company based in Brisbane, California. Appointed in April 2024, he brings over two decades of executive leadership in molecular diagnostics and life sciences, including a decade at Veracyte and a stint as CEO of Apton Biosystems. At CareDx, he is executing a bold three-year plan targeting $500 million in revenue and 20% adjusted EBITDA by 2027, transforming the company from a single-test diagnostics business into a full clinical ecosystem for transplant centers worldwide.

- **Role:** President and CEO at CareDx, Inc.
- **Organizations:** CareDx, Inc., Apton Biosystems, Inc., Pacific Biosciences of California, Inc., Veracyte, Inc., Humana, IBM
- **Nationality:** American
- **Education:** Bachelor of Science, Political Science, Hampden-Sydney College, Master of Business Administration (MBA), University of Miami
- **Known for:** Drove seven consecutive quarters of sequential testing volume growth at CareDx within first year as CEO, Set and executing on a three-year plan targeting $500M revenue and 20% adjusted EBITDA by 2027, Led CareDx to 18% year-over-year revenue growth in Q1 2025 ($84.7M)

## Career timeline

- **2001** — Graduated from Hampden-Sydney College with a BS in Political Science
- **2001-2007** — Early career roles at IBM (sales and business development) and Humana (healthcare leadership)
- **2008** — Earned MBA from University of Miami
- **2011** — Joined Veracyte, Inc. as an early commercial leader in oncology diagnostics
- **2011-2021** — Spent a decade at Veracyte, rising to Chief Commercial Officer and VP of Marketing; drove revenue growth across thyroid, lung, breast, and prostate cancer diagnostics
- **2021-06** — Appointed Chief Executive Officer of Apton Biosystems, Inc., leading development of a high-throughput NGS platform for liquid biopsy
- **2023-08** — Apton Biosystems acquired by Pacific Biosciences of California; Hanna joined PacBio as VP of Corporate Development
- **2024-04-15** — Appointed President and Chief Executive Officer of CareDx, Inc., also joining the Board of Directors
- **2025-04** — Recognized as one of the Top Healthcare Technology CEOs of 2025 by The Healthcare Technology Report
- **2025-05** — CareDx presented landmark AI-powered transplant diagnostics data across 40+ abstracts and 16 oral presentations at the 2025 World Transplant Congress

## Achievements

- Drove seven consecutive quarters of sequential testing volume growth at CareDx within first year as CEO
- Set and executing on a three-year plan targeting $500M revenue and 20% adjusted EBITDA by 2027
- Led CareDx to 18% year-over-year revenue growth in Q1 2025 ($84.7M)
- Oversaw integration of AlloSure Plus AI platform with Epic Aura for seamless clinical workflow
- Led landmark data submission to 2025 World Transplant Congress (40+ abstracts, 16 oral presentations)
- Scaled Veracyte's commercial operations across thyroid, lung, breast, and prostate cancer diagnostics over 10 years
- As CEO of Apton Biosystems, advanced a high-throughput NGS platform for liquid biopsy to acquisition by Pacific Biosciences
- Named Top Healthcare Technology CEO of 2025 by The Healthcare Technology Report
- Transformed CareDx from a single-test diagnostics company into a three-segment clinical platform (lab products, software/patient solutions, genomics)

## Latest updates

- **2025-05** — CareDx presented over 40 abstracts and 16 oral presentations on AI-powered transplant diagnostics at the 2025 World Transplant Congress
- **2025-04** — Named one of The Top Healthcare Technology CEOs of 2025 by The Healthcare Technology Report
- **2025-04** — CareDx posted Q1 2025 revenue of $84.7M, up 18% year-over-year - seventh consecutive quarter of sequential testing volume growth
- **2025-02** — Featured in Mendels Pod interview 'CareDx's Second Act with CEO John Hanna' discussing the company's evolution from single-test to ecosystem
- **2024-12** — AlloSure Plus AI platform integrated with Epic Aura for seamless clinical workflow at transplant centers
- **2024-04** — Appointed President and CEO of CareDx, Inc., effective April 15, 2024

## Links

- Website: https://caredx.com
- LinkedIn: http://www.linkedin.com/in/johnwhanna

---

Profile page: https://yespress.io/john-hanna
Published by YesPress — https://yespress.io
Last updated: 2026-05-16